Home / Meetings and Events

ABOUT CASSS MEETINGS

CASSS meetings bring together industry, regulatory and academic professionals for critical discussions to solve technical and regulatory challenges in the field of biopharmaceutical development. CASSS symposia and fora provide venues for biopharmaceutical professionals to: 

  • Connect with a relevant global network
  • Gain tangible knowledge for career advancement
  • Learn best practices from prominent contributors in the industry

Annually, CASSS holds 13 scientific, multi-day symposia and fora around the world. Attendees represent more than 30 regulatory agencies and over 100 biopharmaceutical companies from Africa, Asia, Australia, Canada, Europe, Latin America, Middle East, and United States.

CASSS also presents three US based regional forums located in the Midwest, Northeast and Northern California. These full-day programs are designed to provide education and networking opportunities for scientists  and emerging professionals who may be unable to attend our global meetings. Discussion groups located in the DC, Netherlands and North Carolina areas provide job-relevant education and networking within the local community. 


  • Image with text 'CMC Strategy Forum Advancing Biopharmaceutical Development Japan' CMC Strategy Forum Japan
    December 6 to 8, 2021

    The Forum will follow the established model of the CMC Forum series with focus on topics and regulatory updates relevant for Japan and Asia Pacific and will take place virtually 6-8 December 2021. Each session will include live speaker presentations and panel discussions, and will last approximately 3.5 hours each day.

  • Image with text 'CMC Strategy Forum Advancing Biopharmaceutical Development North America' CMC Strategy Forum North America
    January 24, 2022

    The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion on relevant CMC issues throughout the lifecycle of a product.

  • Image with text 'WCBP' WCBP
    January 25 to 27, 2022

    The theme for WCBP's 25th anniversary celebration is Pioneering a New Future. The COVID-19 pandemic brought forward unique challenges for the biopharmaceutical industry. The pandemic brought with it disruption that impacted both our professional and personal lives. Our 'return to normal' is a daily reminder that the 'new normal' will be something altogether different than what it was before.

  • Image with text 'HOS Because Structure Matters' International Symposium on the Higher Order Structure of Protein Therapeutics
    April 4 to 6, 2022

    Protein higher-order structure (HOS) and dynamics are essential to protein function. For protein-based therapeutic products, HOS is a critical quality attribute which needs to be monitored to ensure safety and efficacy of drug products. HOS can be monitored by a multitude of biophysical and structural characterization tools. The choice of the appropriate biophysical method and the method development and qualification strategies to characterize and control HOS at different stages of the product lifecycle are a matter of interest and debate for a wide range of audiences.

  • Image with text 'Bioassays Scientific Approaches and Regulatory Strategies' Bioassays: Scientific Approaches & Regulatory Strategies
    April 11 to 13, 2022

    An informative conference on the current thinking, strategies, lessons learned, development and standardization of methods and technologies used for bioassays.

  • image of text 'AT Europe Analytical technologies in the biopharmaceutical industry' Analytical Technologies Europe
    May 22 to 25, 2022

    AT Europe provides an active forum for the discussion of recent developments, regulatory considerations, and practical applications of analytical technologies.

  • Image with text 'Cell & Gene therapy products manufacturing, quality and regulatory considerations' Cell and Gene Therapy Products: Manufacturing, Quality and Regulatory Considerations
    June 6 to 8, 2022

    This symposium enables the exchange of scientific ideas and dialogue with regulators that form the basis of evolving regulatory practices in the development of these diverse and innovative products.

  • Image with text 'CMC Strategy Forum Advancing Biopharmaceutical Development North America' CMC Strategy Forum North America
    July 18 to 19, 2022

    The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion on relevant CMC issues throughout the lifecycle of a product.

  • Image with text 'CE in the Biotechnology & Pharmaceutical Industries' CE in the Biotechnology & Pharmaceutical Industries
    September 18 to 21, 2022

    The goal of the CE Pharm Symposium is to provide a forum for the discussion of recent developments in CE analysis of protein, nucleotide and small molecule pharmaceuticals. The presentations and workshops will be devoted completely to practical concerns to strengthen the use of CE within the biotechnology and pharmaceutical industries.

  • Image with text 'Symposium on the Practical Application of Mass Spectrometry in the Biotechnology Industry' Practical Applications of Mass Spectrometry in the Biotechnology Industry
    September 26 to 29, 2022

    The focus of this Symposium is the practical application of mass spectrometry (MS) in the biotechnology industry. Mass Spectrometry is a critical analytical technology used in the discovery, development, and commercialization of biopharmaceuticals.

  • Image with text 'CMC Strategy Forum Advancing Biopharmaceutical Development Europe' CMC Strategy Forum Europe
    October 17 to 19, 2022

    The Forum will follow the established model of the CMC Forum series with focus on topics and regulatory updates relevant for Europe.